Adaptive changes in glutamatergic signaling within the hypothalamic paraventricular nucleus (PVN) may play a role in the neurohumoral dysfunction underlying the hypertension induced by "slow pressor" angiotensin II (ANG II) infusion. We hypothesized that these adaptive changes alter production of NADPH oxidase (Nox)- 
Introduction
The hypothalamic paraventricular nucleus (PVN) includes neurons containing neurotransmitters, such as glutamate (41, 48) and γ-aminobutyric acid (GABA) (6) , as well as neuromodulators like nitric oxide (NO) (3, 27, 47) . The neurohumoral output from PVN neurons is crucial for coordinating neuroendocrine and autonomic responses, which are thought to play an important role in hypertension (8, 16, 21, 26, 28, 29, 32, 46) . The blood pressure elevation induced by chronic administration of sub-pressor doses of ANG II depends on activation of ANG II type 1 receptors (AT 1 R) in the subfornical organ (SFO) (9, 50) , a circumventricular structure that provides a major excitatory input to pre-sympathetic neurons in the PVN (4, 15) . These PVN neurons are also glutamatergic and project to sympathetic pre-ganglionic neurons in the intermediolateral column of the spinal cord (41) . Since glutamatergic neurotransmission and glutamate receptors in the PVN (5, 19) play a role in the modulation of pre-sympathetic outputs (4, 31, 32) , it is likely these important components of signaling within the SFO to PVN pathway are critical for ANG II-induced "slow-pressor" hypertension (15) .
Oxidative stress induced by NADPH oxidase plays a key role in the mechanisms of ANG II hypertension (33) . Targeting NADPH oxidase to discrete subcellular compartments is an important mechanism for spatial and temporal restriction of ROS production (20, 25, 39, 43, 44, 49, 50) . We have previously shown that a gp91 phox -containing NADPH oxidase (Nox2) is the major source of both N-methyl-D-aspartic acid (NMDA) and ANG II-induced free radicals production in cerebral cortex (18, 22) and selected brainstem nuclei (43) . Therefore, ANG II-induced slow-pressor hypertension may mobilize Nox2 to sites near the NMDAR in PVN neurons, resulting in enhanced ROS production in response to glutamate. Activation of ionotropic glutamate receptors, particularly NMDA receptor (NMDAR)-mediated currents (13, 29, 42) , enhances the production of both neuronal nitric oxide (NO) and reactive oxygen species (ROS) from Nox2 (7, 18, 23) . These agents, either directly or through the formation of peroxynitrite (37) , the reaction product of NO with superoxide, could mediate the adaptive changes in ion channel gating in PVN neurons resulting in the neurohumoral alterations underlying the hypertension.
We used confocal microscopy and electron microscopic immunolabeling to determine whether co-expression of Nox2 and the essential NMDAR subunit NR1 in PVN neurons is affected by chronic systemic administration of a slow-pressor dose of ANG II. We also examined the effect of ANG II-hypertension on NMDAR-mediated Ca 2+ currents using patch-clamp recording in slices, and ROS and NO production in isolated PVN neurons. The results provide new evidence linking enhanced NMDAR-mediated currents, Nox2-dependent ROS production and decreased NO availability in PVN with ANG II slow-pressor hypertension.
Materials and Methods
Animals. Sixty-two male C57Bl/6 mice (age: 8-12 weeks; weight: 21-25 grams) were obtained from an in-house colony. All procedures were approved by the Animal Care and Use Committee at Weill Cornell Medical College. Dihydroethidium (DHE) and 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM) were purchased from Invitrogen (Carlsbad, CA).
Osmotic mini-pump implantation and blood pressure monitor. As described elsewhere (9), wild-type mice were anesthetized (ketamine + xylazine, ip) and implanted subcutaneously with 14-day osmotic mini-pumps (ALZET®; Durect Corporation, Cupertino, CA) loaded with saline or ANG II (600 ng/kg/min), a concentration widely used by us and others (9, 10, 12, 33, 50) . A Hatteras MC-4000 tail-cuff blood pressure system (Cary, NC) was used to document the increase in systolic blood pressure produced by ANG II. In some saline and ANG II-infused mice losartan (1 mg/kg; n=3) or PD123319 (1 mg/kg; n=3) (30) were administered ip, at day 11 for three consecutive days before being sacrificed at day 14.
Electron microscopy. Naïve mice and mice receiving saline or ANG II for 14 days were anesthetized with sodium pentobarbital and their brains were fixed by perfusion with heparin-saline (1000 U/mL) followed consecutively by 3.8% acrolein (Polysciences) in 2% paraformaldehyde/0.1 mol/L phosphate buffer as described previously (13) . A vibratome (Leica Microsystems) was used to cut coronal sections of 40 μm through the PVN according to the brain atlas of (17) . The sections were then freeze-thawed and # A1311, Santa Cruz Biotechnology, Santa Cruz, CA). The antisera were visualized using an immunoperoxidase and immunogold silver labeling protocol that has previously been described in detail and used for electron microscopic analysis of PVN neurons (2, 13) . Analysis of numbers of labeled profiles was done exclusively in tissue processed using immunogold for NR1 and immunoperoxidase for Nox2, but tissue processed using reverse markers was also qualitatively examined in the PVN of mice receiving saline or ANG II. For immune-peroxidase labeling, sections previously incubated with the primary antisera were placed for 30 min in a 1:400 dilution of biotinylated donkey anti- Electron Microscopy Sciences, Hatfield, PA) followed by a 6 minute incubation in silver enhancement IntenSE M (# RPN 491, GE Healthcare, Piscataway, NJ). The immunolabeled tissue was prepared for electron microscopy by processing in 2% osmium tetroxide for 1 hr, followed by dehydration and embedment in Embed 812 resin.
Ultrathin sections collected exclusively at the surface of the tissue were counter-stained and analyzed for ultrastructural analysis using a Tecnai transmission electron microscope (FEI).
Confocal NMDAR NR1 immunostaining. Mice receiving saline or ANG II for 14 days were anesthetized with sodium pentobarbital and their brains were fixed by perfusion with heparin-saline (1000 U/mL) followed by 4% paraformaldehyde/0.1 mol/L phosphate buffer as described previously (13) . A vibratome (Leica Microsystems) was used to cut coronal sections of 40 μm through the PVN according to the brain atlas of (17) . ROS detection. ROS levels in isolated PVN cells were assessed using DHE, as previously described (43) . PVN cells were dissociated as described (13) . In some studies, rhodamine-labeled spinally projecting PVN neurons were first identified using containing the PVN were cut using Leica VT1000s vibratome (Leica Microsystems) and stored in a custom-designed chamber containing lactic acid (l)-aCSF with 95% O 2 and 5% CO 2 at 32°C for one hour. The l-aCSF was composed of (in mmol/L): 124, NaCl; 26, NaHCO 3 ; 5, KCl; 1, NaH 2 PO 4 ; 2, MgSO 4 ; 2, CaCl 2 ; 10, glucose; 4.5, lactic acid; pH 7.4. PVN slices were then transferred to a glass-bottom recording chamber and continuously perfused with gassed l-aCSF at 2 ml/min. The PVN region was identified using lateral ventricle, fornix and optic chiasm as landmarks. Rhodamine-labeled spinal PVN neurons in brain slices were briefly identified under an E600 epifluorescence microscope (Nikon, Japan) with a combination of FITC filter and differential interference contrast optics. Neurons located in the medial one third of the PVN area between the third ventricle and the fornix were patched for whole-cell recording (27) Differences in the number of dendrites co-expressing NR1 and Nox2 in the EM study were statistically evaluated by Chi-square test. For all tests differences were considered statistically significant at P<0.05. For dose-response relationships between ROS/NO formation and NMDA, data were collected when a stable change induced by each dose of NMDA was reached.
Results
Slow-pressor ANG II infusion increases systolic arterial pressure. Infusion of saline for 14 days did not alter systolic arterial pressure (118±3 mmHg at day 0 and 120±3 mmHg at day 14, P>0.05, n=14). However, ANG II infusion (600 ng/kg/min, sc) increased systolic arterial pressure from 117±2 mmHg at day 0 to 140±4 mmHg at day 14 (P<0.01, n=15).
ANG II increases co-localization of Nox2 and NR1 in dendrites of PVN neurons.
Nox2 immunoperoxidase was localized to cytoplasmic endomembranes that were often found near mitochondria and/or plasmalemmal surfaces in the PVN neuropil ( Figure   1A ). Nox2-labeled somata as well as dendrites ( Figure 1B and 1C ) also contained NR1 immunogold, which was affiliated with cytoplasmic endomembranes and the cell surface. Occasionally Nox2 immunoperoxidase labeling was detected in aggregates along non-synaptic portions of the plasma membrane in axon terminals that were presynaptic to dendrites containing NR1-immunogold ( Figure 1D) . A similar subcellular distribution was seen in PVN tissue processed using immunogold for Nox2 and immunoperoxidase for NR1 detection. In this tissue, there were no differences in the plasmalemmal or cytoplasmic density of Nox2 in dendrites in mice receiving ANG II compared with saline (P>0.05). However, ANG II-recipient mice showed significantly more dually labeled Nox2/NR1 dendritic profiles (+48%, P<0.05) than saline-recipient mice in an equal area of PVN neuropil ( Figure 1E ). While Nox2 and NR1 were also often seen in proximity to each other in neuronal soma as well as in glia, these associations were not quantitatively examined. (27, 40) . Therefore, we examined whether ANG II-infusion alters NMDAinduced NO production in isolated PVN cells. Cells from the ANG II group displayed a lower baseline NO than the saline group (P<0.05 vs. saline, n=17-18/group, from 2 mice each) ( Figure 5C ). An example of the time course of immediate changes in NO induced by NMDA in mice receiving saline or ANG II is shown in Figure 5D . NMDA-increased NO signal in the saline-treated group (P<0.05 for 30 µmol/L and P<0.01 for 100 µmol/L vs. vehicle, n=8-10/group, from two mice each), which was prevented by the coapplication with the NOS inhibitor L-NNA (P>0.01 vs. from vehicle, n=8-9/group, from two mice each) ( Figure 5E ) (13) . In the ANG II-treated group, however, NMDA evoked a decrease in the NO signal (P<0.01 vs. vehicle, n=9-10/group, from two mice each), an effect that was reversed by the NADPH oxidase peptide inhibitor gp-91ds-tat (P<0.01 vs. 100 µmol/L NMDA, n=9-10/group, from two mice each) ( Figure 5F ). These data indicate that ANG II infusion suppresses the ability of NMDAR to increase NO, and that the effect depends on NADPH oxidase-derived ROS.
ANG II does not

ANG II enhances NMDAR-mediated currents in PVN neurons. Whole-cell patch-
clamp recordings were performed on neurons located in the medial one third of the PVN area between the third ventricle and the fornix, where NR1 is abundant (Figure 2A-B) and most spinally projecting neurons are located (27) . In saline-infused mice, NMDA (30 µmol/L) reversibly induced an inward current (n=8, from three mice), an effect reversed by washout of NMDA and blocked by MK801 (13). Such current was significantly larger in PVN neurons from ANG II-recipient mice (n=13, from four mice) than saline-recipient mice (P<0.01 vs. saline, n=10, from three mice) ( Figure 6C 
Discussion
There are several novel findings in this study. First, we demonstrated that ANG IIinduced slow pressor hypertension is accompanied by an increase in dendritic colocalization of NMDA NR1 subunits and Nox2 in PVN neurons. Second, we showed that ANG II hypertension is evoked in mice having an increase in Nox2-dependent ROS production and reduced NO in PVN. Third, the increase in ROS production is associated with enhanced glutamatergic NMDAR currents in PVN neurons. 
ANG II increases ROS production and reduces NO levels in PVN.
Another finding of this study is that ANG II increases baseline ROS production and enhances the ROS induced by NMDAR activation. The increase in NMDA-triggered ROS production is consistent with our ultrastructural data indicating that Nox2 and the NMDA receptor subunit NR1 are more frequently co-localized in dendritic compartments in this model of hypertension. In contrast to ROS, baseline NO and NMDA-induced NO increases were reduced in the PVN of mice receiving ANG II infusion. ROS and NO are highly reactive mediators that are co-regulated by complex mechanisms highly dependent on the microdomains in which they are produced (7, 18) . In neocortical neurons, NO triggers ROS production by activating Nox2 via cGMP and protein kinase G (18) . On the other hand, in other models ROS have been shown to reduce NO availability by reacting to form peroxynitrite (37, 45) . The present results suggest that NMDA receptor activation increases both ROS and NO in the PVN of saline-infused mice. However, with ANG II infusion, the increase in ROS produced by NMDA receptor activation is enhanced and is associated with reduced cellular NO levels, suggesting that the excess of ROS acts to suppress NO (45) . In support of this hypothesis, inhibition of ROS production with a NADPH oxidase peptide inhibitor restores NO production in PVN cells. Furthermore, a NO donor is able to attenuate NMDA currents in PVN neurons. ANG II-derived ROS could suppress NO either by formation of peroxynitrite or by inhibiting nNOS enzymatic activity (11, 35, 40) . Irrespective of the mechanisms involved, the present data provide new evidence that ANG II administration alters the balance between NO and ROS in PVN, which in turn, has with profound effects on local glutamatergic signaling.
ANG II enhances NMDA currents in PVN neurons. We also found that ANG II increases the amplitude of NMDA currents in PVN neurons, an effect not associated with increased expression of the NR1 subunit of NMDAR. These findings raise the possibility that in PVN not only AMPA receptors (19, 26) , but also NMDAR may contribute to the heightened pre-sympathetic activity and hypertension produced by systemic ANG II (29, 31) . Indeed, the involvement of NMDAR in PVN is consistent with evidence showing that microinjection of glutamate or NMDA into the PVN increases arterial blood pressure, sympathetic nerve activity, and plasma norepinephrine concentration in rats (31) . We found that bath-applied NMDA induced a noninactivating inward current, which was enhanced in neurons of ANG II-infused mice and was blocked by NMDA receptor antagonist MK801. It remains unclear, however, whether synaptic and/or extrasynaptic NMDA receptors are responsible for this current.
Similar non-inactivating inward currents have been reported in hypothalamic magnocellular neurons, which were mediated by activation of extrasynaptic NMDA receptors (38) . Therefore, further studies will have to address the synaptic or extrasynaptic source of these currents in our preparation.
What are the mechanisms by which ANG II infusion increases NMDA currents in PVN?
ROS are well known to modulate NMDA currents (23, 24) , which may explain why NMDA triggered larger ionic currents in ANG II-infused PVN neurons. Furthermore, local ROS production in dendritic segments may regulate the NMDAR activity by inactivating protein tyrosine phosphatase or by associations with lipid rafts and endosomes that are involved in NMDA receptor trafficking (14). NO could act to suppress NMDA currents by nitrosylating its redox modulatory site (1). Therefore, both increased ROS and reduced NO may participate in the up-regulation of synaptic NMDA currents induced by ANG II. Taken together, our data suggest that increased ROS production, reduced NO, and enhanced NMDAR currents are critical steps in the increase in the output of pre-sympathetic PVN neurons which serve the neurohumoral dysfunction mediating ANG II slow-pressor hypertension. (20, 27, 40, 46) . However, the functional significance of the interaction between NMDAR-mediated NO and ROS in the regulation of sympathetic outflow and blood pressure remains to be defined. Further studies using in vitro and in vivo approaches will be required to address these issues. 
Perspectives and
